Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,981 to 2,000 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD70 antibody-drug conjugate: A potential novel therapeutic agent for ovarian cancer. | Cancer Sci | 2021 | 34117815 | PubTator, text mining | PubMed |
| A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications. | Front Cell Dev Biol | 2021 | 34113610 | PubTator, text mining | PubMed |
| CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma. | Front Neurosci | 2021 | 34113233 | PubTator, text mining | PubMed |
| Proteomic and genomic analysis of acid dentin lysate with focus on TGF-β signaling. | Sci Rep | 2021 | 34112817 | PubTator, text mining | PubMed |
| Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History. | Cancer Discov | 2021 | 34112698 | PubTator, text mining | PubMed |
| Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. | Signal Transduct Target Ther | 2021 | 34108441 | PubTator, text mining | PubMed |
| Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors. | Oncoimmunology | 2021 | 34104544 | PubTator, text mining | PubMed |
| Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications. | Ther Adv Hematol | 2021 | 34104369 | PubTator, text mining | PubMed |
| Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer. | Onco Targets Ther | 2021 | 34103942 | PubTator, text mining | PubMed |
| Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma. | J Exp Clin Cancer Res | 2021 | 34099013 | PubTator, text mining | PubMed |
| GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma. | Cancer Cell Int | 2021 | 34098960 | PubTator, text mining | PubMed |
| CRISPR/Cas9 Gene-Editing in Cancer Immunotherapy: Promoting the Present Revolution in Cancer Therapy and Exploring More. | Front Cell Dev Biol | 2021 | 34095145 | PubTator, text mining | PubMed |
| Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress. | J Hematol Oncol | 2021 | 34090506 | PubTator, text mining | PubMed |
| Searching for new molecular markers for cells obtained from abdominal aortic aneurysm. | J Appl Genet | 2021 | 34080122 | PubTator, text mining | PubMed |
| Potential Role of Hsp70 and Activated NK Cells for Prediction of Prognosis in Glioblastoma Patients. | Front Mol Biosci | 2021 | 34079819 | PubTator, text mining | PubMed |
| Potential Impact of ALKBH5 and YTHDF1 on Tumor Immunity in Colon Adenocarcinoma. | Front Oncol | 2021 | 34079761 | PubTator, text mining | PubMed |
| Comparative Analysis on Abnormal Methylome of Differentially Expressed Genes and Disease Pathways in the Immune Cells of RA and SLE. | Front Immunol | 2021 | 34079550 | PubTator, text mining | PubMed |
| CAR-NK Cells in the Treatment of Solid Tumors. | Int J Mol Sci | 2021 | 34072732 | PubTator, text mining | PubMed |
| Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review. | Cancers (Basel) | 2021 | 34072645 | PubTator, text mining | PubMed |
| DNA Damage Response in the Adaptive Arm of the Immune System: Implications for Autoimmunity. | Int J Mol Sci | 2021 | 34072535 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=100